Tasigna Description

150 mg hard capsules: White to yellowish powder in red opaque hard gelatin capsules, size 1 with black axial imprint "NVR/BCR".
Each capsule contains 150 mg nilotinib base (as hydrochloride, monohydrate).
200 mg hard capsules: White to yellowish powder in light yellow opaque hard gelatin capsules, size 0 with red axial imprint "NVR/TKI".
Each capsule contains 200 mg nilotinib base (as hydrochloride, monohydrate).
Excipients/Inactive Ingredients: 150 mg hard capsules: Capsule content: Lactose monohydrate; Crospovidone; Poloxamer 188; Anhydrous colloidal silica/Colloidal silicon dioxide; Magnesium stearate.
Capsule shell: Gelatin; Titanium dioxide (E171); Iron oxide, red (E172), Iron oxide, yellow (E172).
Printing ink: Shellac; Iron oxide, black (E172); n-Butyl alcohol; Propylene glycol; Dehydrated ethanol; Isopropyl alcohol; Ammonium hydroxide.
200 mg hard capsules: Capsule content: Lactose monohydrate; Crospovidone; Poloxamer 188; Anhydrous colloidal silica/Colloidal silicon dioxide; Magnesium stearate.
Capsule shell: Gelatin; Titanium dioxide (E171); Iron oxide, yellow (E172).
Printing ink: Shellac; Dehydrated alcohol; Isopropyl alcohol; Butyl alcohol; Propylene glycol; Strong ammonia solution; Potassium hydroxide; Titanium dioxide; Industrial methylated spirit; Iron oxide, red (E172), Iron oxide, black (E172).